Groups
|
HC
|
DC
|
RES
|
SLN-RES
|
---|
TAC (mM)
|
0.26 ± 0.04
|
0.12 ± 0.01
|
0.18 ± 0.03α*
|
0.23 ± 0.01α#πδ
|
-SH (mM)
|
0.38 ± 0.06
|
0.17 ± 0.04
|
0.20 ± 0.06
|
0.25 ± 0.08α+
|
MDA (μM)
|
0.48 ± 0.12
|
1.24 ± 0.06
|
0.82 ± 0.12α#
|
0.59 ± 0.03α#π
|
TOS (μmol H2O2 equiv/l)
|
1.40 ± 0.13
|
1.95 ± 0.18
|
1.86 ± 0.15
|
1.59 ± 0.10α#
|
- HC healthy control, DC diabetic control, RES resveratrol treatment 10 mg/kg, SLN-RES resveratrol-loaded solid lipid nanoparticles containing 10 mg/kg of resveratrol, TAC total antioxidant capacity, -SH total thiol group, MDA malondialdehyde, TOS total oxidant status. Data were expressed as mean ± SD
- αCompared to the DC group
- δThere was a significant difference between RES and SLN-RES group (p < 0.05)
- πRestored to the HC group (there was no significant difference compared to the HC group (p > 0.05)).
- *p < 0.05
- +p < 0.01
- #p < 0.001